ArticleSingapore medical journal2026
Evidence-to-Recommendation Framework for 2026 ACE Clinical Guideline on allergic rhinitis - diagnosis and management.
Article in Singapore medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractThis Evidence-to-Recommendation (EtR) framework underpins the ACE Clinical Guideline (ACG) for the diagnosis and management of allergic rhinitis (AR), providing justifications for its recommendations. Allergic rhinitis is highly prevalent in Singapore, with most cases being moderate to severe. While AR is not associated with severe outcomes, poorly controlled or untreated AR can lead to complications, such as asthma, sinusitis or otitis media with effusion. The ACG covers the diagnosis and management of perennial AR, which is the predominant local form of AR and is largely attributed to house dust mites. The Grading of Recommendations Assessment, Development and Evaluation framework was followed to develop four evidence-based recommendations that cover diagnosis, role of allergy testing, and management through pharmacological interventions and allergen avoidance. This EtR framework summarises factors that have informed the direction and strength of the ACG recommendations, including balance of benefits and risks, certainty of evidence, patient preferences and values, resources and feasibility considerations, and acceptability. The ACG can be found at https://go.gov.sg/acg-ar .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.